CAS 684286-46-2

Glimepiride Related Compound A (1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(cis-4-methylcyclohexyl)urea)

CAS: 684286-46-2

Sulfonamides, nesoi

Fórmula: C₂₄H₃₄N₄O₅S

Forma y color: White Powder

Peso molecular: 490.22499

Ref: 45-1292314

Glimepiride EP Impurity A (Glimepiride USP Related Compound A)

CAS: 684286-46-2

Fórmula: C₂₄H₃₄N₄O₅S

Forma y color: White To Off-White Solid

Peso molecular: 490.63

Ref: 4Z-G-065

3-Ethyl-4-methyl-N-(4-(N-((cis-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide

CAS: 684286-46-2

3-Ethyl-4-methyl-N-(4-(N-((cis-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide

Pureza: 97%

Peso molecular: 490.63g/mol

Ref: 54-OR1068650

1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]-3-(cis-4-methylcyclohexyl)urea (cis-Glimepiride)

Producto controlado

CAS: 684286-46-2

Fórmula: C₂₄H₃₄N₄O₅S

Forma y color: Neat

Peso molecular: 490.62

Ref: 86-MM0647.02

Glimepiride EP Impurity A

CAS: 684286-46-2

Fórmula: C₂₄H₃₄N₄O₅S

Peso molecular: 490.62

Ref: ST-EA-CP-G9001

cis-Glimepiride

Producto controlado

CAS: 684286-46-2

Impurity Glimepiride EP Impurity A
Applications cis-Glimepiride (Glimepiride EP Impurity A) is the cis-isomer of Glimepiride found in a bulk drug substance.
References Drummer, O., et al.: Anal. Toxicol., 17, 225 (1993), Magni, F., et al.: Anal. Biochem., 282, 136 (2000), Khan, M., et al.: J. Pharma. Biomed. Anal., 39, 928 (2005),

Fórmula: C₂₄H₃₄N₄O₅S

Forma y color: Neat

Peso molecular: 490.62

Ref: TR-G410145

cis-Glimepiride

CAS: 684286-46-2

Glimepiride is a drug that is used to treat diabetes. It belongs to the class of oral hypoglycaemic drugs, and it is used to lower blood glucose levels in patients with type 2 diabetes mellitus. Glimepiride blocks the breakdown of carbohydrates in the intestine, which leads to an increase in their levels in the bloodstream. This drug has been shown to have synergistic effects with non-steroidal anti-inflammatory drugs (NSAIDs). The mechanism of action for glimepiride is not fully understood, but it may work through its ability to stimulate insulin release from pancreatic beta cells or by inhibiting glucagon secretion from alpha cells. Glimepiride also binds to toll-like receptor 4 (TLR4) on immune cells and inhibits TLR4 signalling pathways.

Fórmula: C₂₄H₃₄N₄O₅S

Pureza: Min. 95%

Peso molecular: 490.62 g/mol

Ref: 3D-FG23667